Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cocktail Therapy (MSDCV + Cyclophosphamide) for HBV-Related Hepatocellular Carcinoma
NCT04317248Phase 2Unknown
- Start
- Apr 2020
- Primary completion
- Apr 2022
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of multiple signals loaded dendritic cells vaccine in hepatocellular carcinoma (HCC). Status: unknown.
02
Drugs
multiple signals loaded dendritic cells vaccine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT04317248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04317248.